Cargando…
Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease
Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combina...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/ https://www.ncbi.nlm.nih.gov/pubmed/29104624 http://dx.doi.org/10.3892/etm.2017.5088 |
_version_ | 1783274056838021120 |
---|---|
author | Hataji, Osamu Nishii, Yoichi Ito, Kentaro Sakaguchi, Tadashi Saiki, Haruko Suzuki, Yuta D'Alessandro-Gabazza, Corina Fujimoto, Hajime Kobayashi, Tetsu Gabazza, Esteban C. Taguchi, Osamu |
author_facet | Hataji, Osamu Nishii, Yoichi Ito, Kentaro Sakaguchi, Tadashi Saiki, Haruko Suzuki, Yuta D'Alessandro-Gabazza, Corina Fujimoto, Hajime Kobayashi, Tetsu Gabazza, Esteban C. Taguchi, Osamu |
author_sort | Hataji, Osamu |
collection | PubMed |
description | Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combination therapy affects daily physical performance in patients with COPD under a smart watch-based encouragement program. This was a non-blinded clinical trial with no randomization or placebo control. A total of 20 patients with COPD were enrolled in the present study. The patients carried an accelerometer for 4 weeks; they received no therapy during the first 2 weeks but they were treated with combined tiotropium and olodaterol under a smart watch-based encouragement program for the last 2 weeks. The pulmonary function test, COPD assessment test, 6-min walk distance and parameters of physical activity were significantly improved (P<0.05) by combination therapy under smart watch-based coaching compared with values prior to treatment. To the best of our knowledge, the present study for the first time provides evidence that smart watch-based coaching in combination with tiotropium and olodaterol may improve daily physical activity in chronic obstructive pulmonary disease. |
format | Online Article Text |
id | pubmed-5658686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-56586862017-11-04 Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease Hataji, Osamu Nishii, Yoichi Ito, Kentaro Sakaguchi, Tadashi Saiki, Haruko Suzuki, Yuta D'Alessandro-Gabazza, Corina Fujimoto, Hajime Kobayashi, Tetsu Gabazza, Esteban C. Taguchi, Osamu Exp Ther Med Articles Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combination therapy affects daily physical performance in patients with COPD under a smart watch-based encouragement program. This was a non-blinded clinical trial with no randomization or placebo control. A total of 20 patients with COPD were enrolled in the present study. The patients carried an accelerometer for 4 weeks; they received no therapy during the first 2 weeks but they were treated with combined tiotropium and olodaterol under a smart watch-based encouragement program for the last 2 weeks. The pulmonary function test, COPD assessment test, 6-min walk distance and parameters of physical activity were significantly improved (P<0.05) by combination therapy under smart watch-based coaching compared with values prior to treatment. To the best of our knowledge, the present study for the first time provides evidence that smart watch-based coaching in combination with tiotropium and olodaterol may improve daily physical activity in chronic obstructive pulmonary disease. D.A. Spandidos 2017-11 2017-09-01 /pmc/articles/PMC5658686/ /pubmed/29104624 http://dx.doi.org/10.3892/etm.2017.5088 Text en Copyright: © Hataji et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Hataji, Osamu Nishii, Yoichi Ito, Kentaro Sakaguchi, Tadashi Saiki, Haruko Suzuki, Yuta D'Alessandro-Gabazza, Corina Fujimoto, Hajime Kobayashi, Tetsu Gabazza, Esteban C. Taguchi, Osamu Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
title | Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
title_full | Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
title_fullStr | Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
title_full_unstemmed | Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
title_short | Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
title_sort | smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/ https://www.ncbi.nlm.nih.gov/pubmed/29104624 http://dx.doi.org/10.3892/etm.2017.5088 |
work_keys_str_mv | AT hatajiosamu smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT nishiiyoichi smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT itokentaro smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT sakaguchitadashi smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT saikiharuko smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT suzukiyuta smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT dalessandrogabazzacorina smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT fujimotohajime smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT kobayashitetsu smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT gabazzaestebanc smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease AT taguchiosamu smartwatchbasedcoachingwithtiotropiumandolodaterolamelioratesphysicalactivityinpatientswithchronicobstructivepulmonarydisease |